Discontinued — last reported Q3 '25
LyondellBasell Industries N.V. Equity Method Investments decreased by 0.9% to $3.93B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 4.5%, from $4.11B to $3.93B. Over 5 years (FY 2020 to FY 2025), Equity Method Investments shows a downward trend with a -3.5% CAGR.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $4.90B | $4.89B | $4.79B | $4.74B | $4.54B | $4.39B | $4.30B | $4.27B | $4.15B | $4.06B | $3.91B | $3.85B | $4.29B | $4.27B | $4.12B | $4.11B | $4.08B | $4.04B | $3.96B | $3.93B |
| QoQ Change | — | -0.3% | -2.1% | -0.9% | -4.2% | -3.5% | -2.1% | -0.7% | -2.7% | -2.3% | -3.7% | -1.6% | +11.6% | -0.4% | -3.5% | -0.2% | -0.8% | -1.0% | -1.9% | -0.9% |
| YoY Change | — | — | — | — | -7.3% | -10.3% | -10.3% | -10.1% | -8.6% | -7.5% | -9.0% | -9.9% | +3.3% | +5.3% | +5.5% | +7.0% | -4.9% | -5.4% | -3.8% | -4.5% |
| Segment | Q4 '21 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q4 '24 | Q4 '25 |
|---|---|---|---|---|---|---|---|---|
| O&P - Americas | $2.12B | $2.05B | $2.04B | $2.03B | $2.01B | $2.05B | $2.01B | $1.96B |
| O&P - EAI | $1.98B | $1.66B | $1.66B | $1.57B | $1.51B | $1.51B | $1.73B | $1.66B |
| I&D | $679.00M | $585.00M | $563.00M | $543.00M | $529.00M | $343.00M | $377.00M | $346.00M |
| APS | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $2.00M | $1.00M | $1.00M |
| Refining | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Technology | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total | $4.79B | $4.30B | $4.27B | $4.15B | $4.06B | $3.91B | $4.12B | $3.96B |
APS, I&D, O&P - Americas, O&P - EAI, Refining, Technology were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.